Week49, 2023
1. Influenza activity is significantly elevated across most of the U.S., with the southeast, south-central, and west coast regions reporting the highest activity levels.
2. Respiratory specimens testing positive for influenza increased to 10.2% this week.
3. Influenza A accounted for 83% of positive specimens, with A(H1N1) the most frequently characterized subtype, while Influenza B made up 17% of detections.
4. Hospital admissions for laboratory-confirmed influenza increased to 7,090 this week, with a cumulative hospitalization rate of 8.0 per 100,000 population this season.
5. Deaths attributed to influenza remained stable at 0.2%, though two new pediatric influenza-associated deaths were reported, raising the seasonal total to 14.
6. Outpatient visits for influenza-like illness (ILI) were 4.4% nationwide, surpassing the national baseline for the sixth consecutive week.
7. CDC estimates there have been at least 3.7 million illnesses, 38,000 hospitalizations, and 2,300 deaths due to influenza this season.
8. Vaccine coverage insights emphasize continued availability, and CDC recommends vaccination for individuals six months or older, as it is not too late to vaccinate.
9. Co-circulation of influenza, COVID-19, and RSV is noted, with integrated weekly data monitoring by CDC, though no novel influenza variants (e.g., H3N2v) have been observed this week.
10. Predictive factors include elevated hospitalization rates among adults aged 65+ (20.3 per 100,000) and children aged 0-4 years, high positivity rates in regions 8, 6, and 4, and an increasing trend of respiratory illness in most surveyed age groups nationwide.